Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
ACQUIRED COMPANY
 
My Lists

Unchained Labs  Acquired by The Carlyle Group (2021 $ 435,000,000 )

6870 Koll Center Parkway Suite 200
Pleasanton, CA 94566
USA
Website Company Summary Management Team
Management

CEO: Tim Harkness (12/31/2014)
General Management: Dustin Giberson (2/28/2016) ; Wilhelm Lachnit (2/23/2015) ; Krista Witte (2/23/2015)
Sales/Marketing: Taegen Clary
Board

Outside board: (May no longer be on the board) Joseph D Keegan (ForteBio Former CEO) Brent Ahrens (Canaan Partners Partner) Heather Preston (TPG Biotech Managing Director) Jack Nielson (Novo A/S Partner) Laura Hamill (Gilead Sciences EVP Commercial Operations)
Company

Business description: Unchained Labs is building the next cool life sciences tools company. One that matters. One without old-school rules. One with products that'll make a real difference in the research scientists do every day. Our Optim products are just the first in a long line of more to come, so stay tuned! The world's first and only multiplex protein stability platform for biologics. Measure more of the protein stability parameters you want, and do it at high speed with ultra-low sample volumes. The first Unchained product, Optim, lets scientists unlock optimal biologic formulations simply and quickly. For the first time, researchers can measure multiple protein stability parameters - including denaturing temperature and aggregation onset temperature - on multiple samples simultaneously. Assays are high throughput, label-free, ultra-low volume and very easy to run.
Capital

Rounds: 4
Recent Fundings: May 2018   Jun 2017
Capital raised: 80.0M
Last Round: 17.0M
Ownership: Acquired by The Carlyle Group (2021 $ 435,000,000 )
VCs include: Canaan Partners TPG Biotech ;  Novo Ventures Novo A/S Tri-Valley Ventures

Last Tweets


 

Last Mentions


Overview
Record updated: Feb 2022
Sector: Medical
Year Founded: 2014
Headcount: 151-200 as of Feb 2022
Rounds: 4
Recent Fundings: May 2018   Jun 2017
Capital Raised: 80.0M
Last Round: 17.0M
Ownership: Acquired by The Carlyle Group (2021 $ 435,000,000 )